AOD-9604 in Obesity Problems and Fat Burning AOD-9604 as a lipolytic fragment of HGH was developed and thereafter studied most of all for its effective fat burning functions and as a potential anti-obesity drug
The compounds identified were galangin, kaempferide, -sitosterol, 1-(4-hydroxy-3-methoxyphenyl)-7-phenyl-3,5-heptanediol, 5-hydroxy-7-(4-hydroxyphenyl)-1-phenyl-3-hepta none, 3- O --D-6-palmitoylgluco side (3 R ,5 R )-1-(4-hydroxyphenyl)-7-phenyl-3,5-heptanediol, (5R)-5-hydroxy-7-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)-3-heptanone, and 5-hy droxy-1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)-3-hept anone (Shin et al., 2002)
The TRIUMPH-4 Phase 3 trial in obesity with knee osteoarthritis later reported 28.7% mean weight loss at 68 weeks with retatrutide 12 mg/week, and identified a dose-related dysesthesia (nerve-tingling) signal in 8.8% of 9 mg and 20.9% of 12 mg patients (Bays et al., 2025)
Disclaimer Disclaimer: Products sold by Protide Health are for laboratory research purposes only and are not intended for human consumption, medical use, or veterinary use
There is no listed drug interaction, no contraindication, and no specific warning about alcohol use
